T-cell Lymphoblastic Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Lymphoblastic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Venetoclax and Decitabine in R/R T-ALL [Phase 2]
Phase 2 clinical trial of venetoclax and decitabine for relapsed/refractory T-cell acute lymphoblastic leukemia is currently recruiting at S…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL [Phase 2]
Phase II trial evaluating the safety and efficacy of CB-103 in combination with Venetoclax for relapsed/refractory T-cell acute lymphoblasti…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia [Phase 1]
Phase 1 trial of XmAb18968 (CD3-CD38) in relapsed or refractory acute myeloid leukemia and T-cell lymphoblastic leukemia/lymphoma has been t…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL [EARLY_Phase 1]
A Phase 1 trial evaluating CD7-directed CAR-T therapy for relapsed/refractory CD7-positive T-cell acute lymphoblastic leukemia and T-lymphob…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL [EARLY_Phase 1]
A Phase 1 trial evaluating RD13-02 CAR-T cell therapy for relapsed/refractory CD7-positive T-cell acute lymphoblastic leukemia and T-lymphob…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL) [Phase 2]
Phase 2 clinical trial update for 506U78 in relapsed or refractory acute lymphoblastic leukemia (T-ALL) and T-NHL (lymphoblastic).
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma [Phase 3]
A Phase 3 clinical trial evaluating combination chemotherapy with or without bortezomib in younger patients with newly diagnosed T-cell acut…
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma [Phase 3]
A Phase 3 trial evaluating whether adding bortezomib to combination chemotherapy improves outcomes in younger patients with newly diagnosed …
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL [Phase 1, Phase 2]
Phase 1/2 trial evaluating nelarabine combined with etoposide and cyclophosphamide in relapsed T-cell ALL and T-cell lymphoblastic lymphoma;…
-
CLINICAL_TRIALS trial_result · 2019-06-20Clinical Trial Update: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma [Phase 3]
Phase 3 clinical trial update on combination chemotherapy for newly diagnosed T-cell acute lymphoblastic leukemia or T-cell lymphoblastic ly…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL [Phase 1, Phase 2]
Clinical trial update for LY3039478 in combination with dexamethasone in T-ALL/T-LBL (Phase 1/Phase 2) completed with results posted in 2019…
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg
Clinical trial update reporting a drug use investigation for nelarabine (ARRANON G) injection 250 mg.
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors [Phase 1]
Phase 1 pilot study evaluating donor-derived natural killer cell infusions for refractory non-B lineage hematologic cancers and solid tumors…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma [NA]
Clinical trial update on the use of 506U78 for relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma;…